MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 3 | 0.0 |
Animals | 22 | 0.0 |
Humans | 58 | 0.0 |
Mice | 8 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Rats | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Female | 16 | 0.0 |
Incontinentia Pigmenti/*genetics | 10 | 62.0 |
Male | 11 | 0.0 |
*X Chromosome | 9 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Adult | 8 | 0.0 |
Reference Values | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Cells, Cultured | 10 | 0.0 |
Inositol Phosphates/biosynthesis | 2 | 8.0 |
Magnesium/pharmacology | 2 | 1.0 |
Neomycin/pharmacology | 3 | 15.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
Transfection | 3 | 0.0 |
Adenylate Cyclase/metabolism | 2 | 1.0 |
Cell Line | 10 | 0.0 |
Phospholipase C/metabolism | 4 | 1.0 |
*Signal Transduction | 3 | 0.0 |
Atropine/pharmacology | 2 | 5.0 |
Base Sequence | 5 | 0.0 |
Carbachol/*pharmacology | 2 | 20.0 |
Phosphatidylinositols/*metabolism | 8 | 9.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Stimulation, Chemical | 4 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Inositol 1,4,5-Trisphosphate/*metabolism | 2 | 20.0 |
Neutrophils/*metabolism | 2 | 1.0 |
Bradykinin/pharmacology | 3 | 6.0 |
Calcium/metabolism | 6 | 0.0 |
Comparative Study | 7 | 0.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Hydrolysis | 6 | 0.0 |
Phosphatidylinositols/metabolism | 4 | 3.0 |
Chromosome Mapping | 9 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
*Chromosomes, Human, Pair 9 | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*Translocation, Genetic | 6 | 0.0 |
Calcium Channel Blockers/pharmacology | 2 | 2.0 |
Gallic Acid/analogs & derivatives/pharmacology | 2 | 12.0 |
Pertussis Toxin | 4 | 2.0 |
Virulence Factors, Bordetella/pharmacology | 5 | 2.0 |
Calcium/pharmacology | 2 | 0.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
Aged | 4 | 0.0 |
Middle Aged | 6 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Inositol Phosphates/metabolism | 9 | 6.0 |
Calcium/*metabolism | 5 | 0.0 |
Signal Transduction | 4 | 0.0 |
Carbachol/pharmacology | 2 | 2.0 |
Cyclic AMP/biosynthesis | 2 | 1.0 |
Forskolin/pharmacology | 2 | 0.0 |
Hamsters | 7 | 0.0 |
Inositol Phosphates/*metabolism | 5 | 15.0 |
Hybrid Cells | 5 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Chromosome Banding | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
Pigmentation Disorders/*genetics | 3 | 30.0 |
Pedigree | 2 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 3 | 1.0 |
*Genetic Markers | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Blood Platelets/*metabolism | 2 | 0.0 |
Phosphatidylinositols/*blood | 2 | 20.0 |
Thrombin/pharmacology | 2 | 0.0 |
In Vitro | 6 | 0.0 |
Inositol/metabolism | 2 | 8.0 |
Kinetics | 8 | 0.0 |
Blood Platelets/drug effects/*metabolism | 3 | 4.0 |
Inositol Phosphates/blood | 2 | 40.0 |
Molecular Weight | 3 | 0.0 |
Oxytocin/*pharmacology | 2 | 11.0 |
Pregnancy | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Cricetulus | 2 | 0.0 |
DNA Probes | 3 | 0.0 |
Inositol Phosphates/*biosynthesis | 2 | 25.0 |
Thyrotropin/*pharmacology | 2 | 6.0 |
Temperature | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 11.0 |
Thionucleotides/pharmacology | 2 | 3.0 |
Inositol 1,4,5-Trisphosphate | 2 | 11.0 |
N-Formylmethionine Leucyl-Phenylalanine/pharmacology | 2 | 0.0 |
Inositol Phosphates/*blood | 2 | 50.0 |
Sugar Phosphates/*blood | 2 | 50.0 |
Phospholipase C/*metabolism | 2 | 1.0 |
*Brain Chemistry | 2 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Myelin Proteins/*analysis | 2 | 13.0 |
